Tonix Pharmaceuticals (TNXP)
(Delayed Data from NSDQ)
$0.15 USD
-0.01 (-3.88%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $0.16 +0.01 (4.03%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Tonix Pharmaceuticals Holding Corp. [TNXP]
Reports for Purchase
Showing records 61 - 80 ( 154 total )
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
2Q16 Recap - Tonmya Catalyst Coming in September
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Termination of Coverage-Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: GRISEWOOD S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
PTSD Data Presentation Validates Potential of TNX-102 SL
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
1Q16 Recap - Catalysts Approaching in Late May and 3Q16
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Tonix Pharmaceuticals Holding Corp.
Industry: Medical - Drugs
Updated Model, PTSD Readout Likely in Mid-to-Late May
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S